Published in Indian J Med Res on July 01, 1985
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
Thottapalayam virus: a presumptive arbovirus isolated from a shrew in India. Indian J Med Res (1971) 2.52
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
A study on chikungunya outbreak during 2007 in Kerala, south India. Indian J Med Res (2009) 1.49
Impact of lambdacyhalothrin capsule suspension treated bed nets on malaria in tribal villages of Malkangiri district, Orissa, India. Indian J Med Res (2008) 1.48
Dual infection by dengue virus and Plasmodium vivax in Alappuzha District, Kerala, India. Jpn J Infect Dis (2006) 1.48
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
Larvicidal & emergence inhibitory activities of NeemAzal T/S 1.2 per cent EC against vectors of malaria, filariasis & dengue. Indian J Med Res (2009) 1.44
Epidemiology of animal bites and rabies cases in India. A multicentric study. J Commun Dis (2008) 1.42
Laboratory evaluation of methanolic extract of Atlantia monophylla (Family: Rutaceae) against immature stages of mosquitoes and non-target organisms. Mem Inst Oswaldo Cruz (2004) 1.41
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
Evidence for the use of albendazole for the elimination of lymphatic filariasis. Lancet Infect Dis (2006) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res (1989) 1.29
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
Prevalence of bancroftian filariasis & its control by single course of diethyl carbamazine in a rural area in Tamil Nadu. Indian J Med Res (1989) 1.24
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. Bull World Health Organ (2007) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas. Trans R Soc Trop Med Hyg (2011) 1.17
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Transmembrane helix prediction using amino acid property features and latent semantic analysis. BMC Bioinformatics (2008) 1.15
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
The mosquito problem and type and costs of personal protection measures used in rural and urban communities in Pondicherry region, South India. Acta Trop (2003) 1.10
Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg (1996) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect (1989) 1.07
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Impact of alphacypermethrin treated bed nets on malaria in villages of Malkangiri district, Orissa, India. Acta Trop (2003) 1.05
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Diagnostic methods for detection & isolation of dengue viruses from vector mosquitoes. Indian J Med Res (2006) 1.05
Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion. Biochem J (1999) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
In vitro screening of medicinal plant extracts for macrofilaricidal activity. Parasitol Res (2006) 1.04
The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology (1998) 1.04
Diversity and divergence among the tribal populations of India. Ann Hum Genet (2005) 1.04
The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (2004) 1.03
Larvicidal activity of Saraca indica, Nyctanthes arbor-tristis, and Clitoria ternatea extracts against three mosquito vector species. Parasitol Res (2008) 1.03
Control of malaria and filariasis vectors in South India. Parasitol Today (1987) 1.03
The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med (1998) 1.03
Extraosseous Ewing's sarcoma of the kidney. Urol Int (2002) 1.02
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol (1997) 1.02
Larvicidal & synergestic activity of plant extracts for mosquito control. Indian J Med Res (1985) 1.02
Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg (1998) 1.02
Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res (1993) 1.00
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell Dev Biol Anim (1997) 1.00
Seasonal abundance & biting behaviour of Mansonia annulifera, M. uniformis & M. indiana & their relative role in the transmission of malayan filariasis in Shertallai (Kerala state). Indian J Med Res (1991) 1.00
Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis (1997) 1.00
Clinical epidemiology of bancroftian filariasis: effect of age and gender. Trans R Soc Trop Med Hyg (1991) 0.99
Parasitological aspects of malaria persistence in Koraput district Orissa, India. Indian J Med Res (1990) 0.99
Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Indian J Med Res (2000) 0.98
Pharmacological actions of Shilajit. Indian J Exp Biol (1988) 0.98
Microlevel epidemiological variations in malaria & its implications on control strategy. Indian J Med Res (1991) 0.97
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Trop Med Int Health (2002) 0.97
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. Cochrane Database Syst Rev (2007) 0.97
Evidence of a laminin binding protein on the surface of Leishmania donovani. Biochem Biophys Res Commun (1996) 0.96
A random-sum Wilcoxon statistic and its application to analysis of ROC and LROC data. J Stat Plan Inference (2010) 0.96
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol (2005) 0.96
Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health (2009) 0.96
Engineering, mosquitoes and filariasis: a case report. J Trop Med Hyg (1988) 0.96
Localization of alpha-fetoprotein in human and rat fetal livers. An immunohistochemical method using horseradish peroxidase. J Histochem Cytochem (1974) 0.95
Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol (2006) 0.95
Phagocytosis by normal human melanocytes in vitro. Exp Cell Res (1993) 0.95
Operational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes. Trop Med Int Health (2006) 0.94
Disappearing bone disease: a case report. Singapore Med J (1994) 0.94
Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively. J Immunol (1998) 0.94
Knowledge, attitude and practice towards malaria in rural communities of the epidemic-prone Thar Desert, northwestern India. J Commun Dis (1999) 0.94